Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-13

Clinical Trial Update: Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the response and non-response to nirogacestat in desmoid tumors; study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nirogacestat (nirogacestat)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Tumor | Phase 2 | Status: RECRUITING